Pfizer axes development of Duchenne muscular dystrophy antibody Pfizer has axed trials of its domagrozumab antibody for Duchenne muscular dystrophy (DMD), after it failed against efficacy targets.

Software Development Software Development | News, how-tos, features, reviews, and videos Explore related topics APIs Application Integration Application Life Cycle Management Development Approaches ...

Sarepta Therapeutics has followed through on its promise to file for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy (DMD), as it aims for a launch in the middle of ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing, followed by ...

Standards make everyday life run smoothly. You rarely notice them: the credit card that works in any corner of the world, the Wi-Fi signal that connects a remote village to the cloud, or the vaccine ...

Pakistan enters 2026 with surprisingly warmer ties to the United States – a sharp turn from the chill of recent years. In a ...

Congress leader Manickam Tagore has reacted sharply to reports that allies of Tamil Nadu's ruling DMK with whom the Congress ...

This report sets out the argument that development has been incorrectly focused around solely increasing national incomes, with little focus paid to other metrics. As Seers says in his introduction: ...